First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
Imaging Technology
JUNE 15, 2023
It will also determine the optimal timing for a patient scan following the administration of 18F-CD8 PET, which would be within the same day and, potentially, as soon as one hour, reducing the need for separate or multiple visits - providing more convenience for patients. Lancet Oncology 2023; 24(3): e133-e143.
98 
Let's personalize your content